A Study in Healthy Men to Test How BI 1815368 is Processed in the Body
18h agoen
From the article
Conditions : Healthy Interventions : Drug: BI 1815368 (C-14); Drug: BI 1815368 (C-13) Sponsors : Boehringer Ingelheim Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Cybin: 51 Prozent Plus auf Monatssicht
aktiencheck.de
Outlook Therapeutics Aktie: FDA-Entscheidung am 29. Juli 2026
aktiencheck.de
Roche Aktie: Neue Alzheimer-Daten im Juli
aktiencheck.de
CELEX:32026R1421: RĂšglement dâexĂ©cution (UE) 2026/1421 de la Commission du 30 juin 2026 modifiant le rĂšglement dâexĂ©cution (UE) no 540/2011 en ce qui concerne la prolongation de la pĂ©riode dâapprobation des substances actives bensulfuron, benzovindiflupyr
europol.europa.eu·8d ago
CELEX:32026D1420: DĂ©cision dâexĂ©cution (UE) 2026/1420 de la Commission du 30 juin 2026 relative Ă la non-approbation de la terbutryne, de la 1,2-benzisothiazole-3(2H)-one (BIT) et de la tĂ©trahydro-1,3,4,6-tĂ©trakis(hydroxymĂ©thyl)imidazo[4,5-d]imidazole-2,5
europol.europa.eu·6d ago
Anixa Biosciences Aktie: Höchste Lira-cel-Dosis erreicht
aktiencheck.de
Comments
Sign in to join the conversation.
No comments yet. Be the first.